Skip to content
10-Q

Quarterly Report

Applied Therapeutics, Inc.

0001193125-25-278818

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 144.3M sh
Shares Diluted Q3 2025 · Sep 30, 2025 145.56M sh
Shares Diluted Q3 2025 · Sep 30, 2025 145.15M sh
Shares Diluted Q3 2025 · Sep 30, 2024 144.35M sh
Shares Diluted Q3 2025 · Sep 30, 2024 137.89M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$67.38M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$64.84M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $11.95M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $79.4M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$561K
Stockholders Equity Q3 2025 · Jun 30, 2025 $17.44M
Stockholders Equity Q3 2025 · Mar 31, 2025 $36.67M
Stockholders Equity Q3 2025 · Dec 31, 2024 $57.01M
Stockholders Equity Q3 2025 · Sep 30, 2024 $5.89M
Stockholders Equity Q3 2025 · Jun 30, 2024 $72.39M
Stockholders Equity Q3 2025 · Mar 31, 2024 $67.29M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$17.15M
Current Liabilities Q3 2025 · Sep 30, 2025 $32.9M
Current Liabilities Q3 2025 · Dec 31, 2024 $27.3M
Total Liabilities Q3 2025 · Sep 30, 2025 $34.94M
Total Liabilities Q3 2025 · Dec 31, 2024 $29.69M
Current Assets Q3 2025 · Sep 30, 2025 $31.65M
Current Assets Q3 2025 · Dec 31, 2024 $83.65M
Total Assets Q3 2025 · Sep 30, 2025 $34.37M
Total Assets Q3 2025 · Dec 31, 2024 $86.69M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.13
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.43
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.48
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.09
Eps Basic Q3 2025 · Sep 30, 2025 −$0.13
Eps Basic Q3 2025 · Sep 30, 2025 −$0.43
Eps Basic Q3 2025 · Sep 30, 2024 −$0.48
Eps Basic Q3 2025 · Sep 30, 2024 −$1.09
Sga Expense Q3 2025 · Sep 30, 2025 $8.16M
Sga Expense Q3 2025 · Sep 30, 2025 $39.02M
Sga Expense Q3 2025 · Sep 30, 2024 $15.04M
Sga Expense Q3 2025 · Sep 30, 2024 $34.68M
Rd Expense Q3 2025 · Sep 30, 2025 $9.6M
Rd Expense Q3 2025 · Sep 30, 2025 $27.36M
Rd Expense Q3 2025 · Sep 30, 2024 $14.83M
Rd Expense Q3 2025 · Sep 30, 2024 $37.05M
Net Income Q3 2025 · Sep 30, 2025 −$18.99M
Net Income Q3 2025 · Sep 30, 2025 −$62.15M
Net Income Q3 2025 · Jun 30, 2025 −$21.33M
Net Income Q3 2025 · Mar 31, 2025 −$21.83M
Net Income Q3 2025 · Sep 30, 2024 −$68.59M
Net Income Q3 2025 · Sep 30, 2024 −$149.63M
Net Income Q3 2025 · Jun 30, 2024 $2.9M
Net Income Q3 2025 · Mar 31, 2024 −$83.94M
Operating Income Q3 2025 · Sep 30, 2025 −$16.76M
Operating Income Q3 2025 · Sep 30, 2025 −$65.38M
Operating Income Q3 2025 · Sep 30, 2024 −$29.74M
Operating Income Q3 2025 · Sep 30, 2024 −$71.28M
Revenue Q3 2025 · Sep 30, 2025 $1M
Revenue Q3 2025 · Sep 30, 2025 $1M
Revenue Q3 2025 · Sep 30, 2024 $122K
Revenue Q3 2025 · Sep 30, 2024 $455K